Pfizer Names Cecile Guegan as CFO and Raises 2026 Outlook Following Q3 Beat

Source Summary

Pfizer announced the appointment of Cecile Guegan as Chief Financial Officer and raised its full-year 2026 financial outlook following better-than-expected third-quarter results. The company's Q3 performance exceeded analyst expectations, prompting management to increase guidance for the coming year.

Why it matters

The CFO appointment and raised guidance signal management confidence in Pfizer's financial trajectory and operational performance.

Read the Source

Seeking Alpha ↗

NYSE:PFELive chart

Trading trends

The chart totals every SEC-reported transaction by month and share count, separating informative purchases and sales from non-informative awards, vesting, exercises, tax withholding and transfers. Records without a reported price remain included. Only informative purchases and sales affect the conservative sentiment signal.

Recent SEC-reported share and derivative transactions in PFIZER INC.

Insider activity sentiment

Bullish

BearishNeutralBullish

3 discretionary purchases · 1 discretionary sales

Confidence: High

Informative buyNon-informative buyInformative sellNon-informative sell

Insiders	Activity	Description	Shares	Avg. price / share	Est. value	Trade date
Chairman & CEOBOURLA ALBERT	Non-informative buy	Phantom Stock Units SSPCompany grant or award (A)	20	—	—	Oct 15, 2026
Chairman & CEOBOURLA ALBERT	Non-informative buy	Phantom Stock Units SSPCompany grant or award (A)	71	—	—	Oct 13, 2026
Chairman & CEOBOURLA ALBERT	Non-informative buy	Phantom Stock Units SSPCompany grant or award (A)	21	—	—	Sep 30, 2026
DirectorBuckley Mortimer J	Non-informative buy	Phantom Stock UnitsCompany grant or award (A)	1,307.99	—	—	Sep 25, 2026
DirectorEchevarria Joseph	Non-informative buy	Phantom Stock UnitsCompany grant or award (A)	1,613.19	—	—	Sep 25, 2026

As filed with the SEC. Estimated value is shown only for purchases or sales with a positive reported transaction price; awards, gifts and similar activity are not assigned an assumed market value. Amendments may change the record. This is not investment advice.

Short interest

Open short positions reported twice monthly; this is not daily short-sale volume.

Earnings

Recent reported earnings per share compared with the analyst consensus available from Nasdaq.

Comments

No published comments yet.

Owner	Activity	Change	Shares held	Value (thousands)	Reported
Vanguard Group Inc	Buy	1,206,169 (0.223%)	541,346,182	$16,603,087	12/31/2025
Blackrock, Inc.	Buy	31,412,883 (6.305%)	529,670,433	$16,244,992	6/30/2026
Vanguard Capital Management Llc	Buy	2,719,840 (0.736%)	372,149,852	$11,413,836	6/30/2026
State Street Corp	Buy	5,501,032 (1.824%)	307,090,897	$9,418,478	6/30/2026
Geode Capital Management, Llc	Buy	1,714,040 (1.283%)	135,275,782	$4,148,908	6/30/2026
Vanguard Portfolio Management Llc	Buy	2,500,335 (2.142%)	119,235,030	$3,656,938	6/30/2026
Fisher Asset Management, Llc	Buy	4,102,864 (3.909%)	109,067,291	$3,345,094	6/30/2026
Morgan Stanley	Buy	3,660,082 (3.949%)	96,345,452	$2,954,915	6/30/2026
Norges Bank	Sell	-12,027,991 (-16.357%)	61,505,586	$1,886,376	6/30/2026
Northern Trust Corp	Sell	-2,941,979 (-4.743%)	59,084,573	$1,812,124	6/30/2026
Bank Of New York Mellon Corp	Buy	3,999,646 (7.423%)	57,879,546	$1,775,166	6/30/2026
Massachusetts Financial Services Co /Ma/	Sell	-360,819 (-0.634%)	56,551,011	$1,734,420	6/30/2026

Settlement date	Short interest	Avg. daily volume	Change vs. previous report	Days to cover
Oct 15, 2026	137,816,093	30,826,887	-8.26%	4.47
Sep 30, 2026	150,217,617	34,031,762	-3.21%	4.41
Sep 15, 2026	155,202,257	31,657,403	+2.42%	4.90
Aug 31, 2026	151,537,890	35,022,905	+1.52%	4.33
Aug 14, 2026	149,271,132	42,256,400	-7.56%	3.53
Jul 31, 2026	161,478,227	38,594,371	-1.43%	4.18
Jul 15, 2026	163,820,439	42,807,581	+0.15%	3.83
Jun 30, 2026	163,578,117	60,914,282	+0.93%	2.69

Fiscal quarter	Reported	EPS	Consensus	Surprise
Jun 2026	Aug 4, 2026	0.77	0.68	+13.24%
Mar 2026	May 5, 2026	0.75	0.71	+5.63%
Dec 2025	Feb 3, 2026	0.66	0.57	+15.79%
Sep 2025	Nov 4, 2025	0.87	0.66	+31.82%

Source Summary

Why it matters

Read the Source

NYSE:PFE — Live chart

Insider activity sentiment

Comments

Related stories

Gartner Stock Surges 31.2% Following Strong Q2 Earnings Beat

UnitedHealth Group Raises Profit Forecast After Third-Quarter Earnings Beat

Best Buy Beats Estimates and Raises Outlook Despite Stock Decline

Comments

Insider activity sentiment

NYSE:PFELive chart